NeoGenomics, Inc.
12701 Commonwealth Drive
Suite 9
Fort Myers
Florida
33913
United States
Tel: 239-768-0600
Fax: 239-768-0711
Website: http://www.neogenomics.org/
Email: info@neogenomics.org
268 articles about NeoGenomics, Inc.
-
NeoGenomics, Inc. Validates and Launches NeoSITE™ Barrett's Esophagus FISH Test for Surveillance and Diagnosis of High Grade Dysplasia/Esophageal Cancer
12/17/2012
-
NeoGenomics, Inc. to Ring the NASDAQ Stock Market Closing Bell
12/12/2012
-
NeoGenomics, Inc. Announces NASDAQ Capital Market Listing
12/6/2012
-
NeoGenomics, Inc. Reports 42% Test Volume Growth, 26% Revenue Growth and 22% Increase in Adjusted EBITDA for the Third Quarter 2012
10/31/2012
-
NeoGenomics, Inc. Schedules its Q3 2012 Earnings Release for October 31, 2012
10/24/2012
-
NeoGenomics, Inc. Develops and Implements Proprietary Method for Automating and Interpreting Fluorescence In-Situ Hybridization Test Data
9/14/2012
-
NeoGenomics, Inc. Launches NeoTYPE&0153 Prognostic Panel for Chronic Lymphocytic Leukemia; Includes First U.S. Clinical Molecular Test for SF3B1 Mutations
8/6/2012
-
NeoGenomics, Inc. Reports 49% Revenue Growth, Adjusted EBITDA of $1.9 million and Net Income of $550,000 for the Second Quarter 2012
7/20/2012
-
NeoGenomics, Inc. Significantly Expands Molecular Testing Menu and Launches NeoTYPE™ Cancer Profile Panels
7/18/2012
-
NeoGenomics, Inc. Schedules its Q2 2012 Earnings Release for July 19, 2012
7/10/2012
-
NeoGenomics, Inc. Reports 72% Revenue Growth, 85% Gross Profit Growth and $1.5 Million Increase in Net Income for Q1 2012
4/25/2012
-
NeoGenomics, Inc. Schedules Its Q1 2012 Earnings Release for April 25, 2012
4/18/2012
-
NeoGenomics, Inc. Announces Increase in the Maximum Availability Under its Revolving Credit Facility
3/29/2012
-
NeoGenomics, Inc. Announces Upward Revision to Q1 2012 Revenue Guidance
3/5/2012
-
NeoGenomics, Inc. Reports 47% Revenue Growth and Profitability for Q4 2011; Provides Financial Outlook for 2012
2/16/2012
-
NeoGenomics, Inc. Schedules its Q4 and Full Year 2011 Earnings Release for February 16, 2012
2/8/2012
-
NeoGenomics, Inc. Enters Into Exclusive Worldwide Licensing Agreement With Health Discovery Corporation
1/9/2012
-
NeoGenomics, Inc. Appoints Dr. Maher Albitar as Chief Medical Officer
1/9/2012
-
Health Discovery Corporation Enters into Worldwide Licensing Agreement with NeoGenomics, Inc.
1/9/2012
-
NeoGenomics, Inc. Appoints Dr. Barbara Chaitin as Director of Surgical Pathology and Medical Director for its Florida Lab
1/5/2012